Bliek Jet, Verde Gaetano, Callaway Jonathan, Maas Saskia M, De Crescenzo Agostina, Sparago Angela, Cerrato Flavia, Russo Silvia, Ferraiuolo Serena, Rinaldi Maria Michela, Fischetto Rita, Lalatta Faustina, Giordano Lucio, Ferrari Paola, Cubellis Maria Vittoria, Larizza Lidia, Temple I Karen, Mannens Marcel M A M, Mackay Deborah J G, Riccio Andrea
Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Eur J Hum Genet. 2009 May;17(5):611-9. doi: 10.1038/ejhg.2008.233. Epub 2008 Dec 17.
Genomic imprinting is an epigenetic phenomenon restricting gene expression in a manner dependent on parent of origin. Imprinted gene products are critical regulators of growth and development, and imprinting disorders are associated with both genetic and epigenetic mutations, including disruption of DNA methylation within the imprinting control regions (ICRs) of these genes. It was recently reported that some patients with imprinting disorders have a more generalised imprinting defect, with hypomethylation at a range of maternally methylated ICRs. We report a cohort of 149 patients with a clinical diagnosis of Beckwith-Wiedemann syndrome (BWS), including 81 with maternal hypomethylation of the KCNQ1OT1 ICR. Methylation analysis of 11 ICRs in these patients showed that hypomethylation affecting multiple imprinted loci was restricted to 17 patients with hypomethylation of the KCNQ1OT1 ICR, and involved only maternally methylated loci. Both partial and complete hypomethylation was demonstrated in these cases, suggesting a possible postzygotic origin of a mosaic imprinting error. Some ICRs, including the PLAGL1 and GNAS/NESPAS ICRs implicated in the aetiology of transient neonatal diabetes and pseudohypoparathyroidism type 1b, respectively, were more frequently affected than others. Although we did not find any evidence for mutation of the candidate gene DNMT3L, these results support the hypotheses that trans-acting factors affect the somatic maintenance of imprinting at multiple maternally methylated loci and that the clinical presentation of these complex cases may reflect the loci and tissues affected with the epigenetic abnormalities.
基因组印记是一种表观遗传现象,它以一种依赖于亲本来源的方式限制基因表达。印记基因产物是生长和发育的关键调节因子,印记障碍与遗传和表观遗传突变相关,包括这些基因的印记控制区域(ICR)内DNA甲基化的破坏。最近有报道称,一些患有印记障碍的患者存在更广泛的印记缺陷,一系列母源甲基化的ICR出现低甲基化。我们报告了一组149例临床诊断为贝克威思-维德曼综合征(BWS)的患者,其中81例KCNQ1OT1 ICR存在母源低甲基化。对这些患者的11个ICR进行甲基化分析表明,影响多个印记位点的低甲基化仅限于17例KCNQ1OT1 ICR低甲基化的患者,且仅涉及母源甲基化位点。在这些病例中均证实了部分和完全低甲基化,提示可能存在合子后起源的嵌合印记错误。一些ICR,包括分别与短暂性新生儿糖尿病和1b型假性甲状旁腺功能减退病因相关的PLAGL1和GNAS/NESPAS ICR,比其他ICR更频繁地受到影响。尽管我们没有发现候选基因DNMT3L发生突变的任何证据,但这些结果支持以下假设:反式作用因子影响多个母源甲基化位点印记的体细胞维持,并且这些复杂病例的临床表现可能反映了受表观遗传异常影响的位点和组织。